An 11-year-old Long Island boy is battling leukemia, and the community has rallied around him to raise nearly $100,000 for ...

Researchers have introduced a novel diagnostics method that can more sensitively detect gene fusions in B-cell acute ...

The U.S. Food and Drug Administration (FDA) on Wednesday granted accelerated approval to BeOne Medicines Ltd.‘s ONC Beqalzi ...

Aptose Biosciences has scrapped a deal for a blood cancer drug candidate as part of its pending takeover by Hanmi ...

This biotech specializes in small molecule kinase inhibitors for cancer, with lead drug candidates in early-stage clinical ...

A nurse practitioner from Eldridge has been honored for her work to organize blood drives and advocate for pediatric cancer ...

The 2025 Light The Night Executive Challenge raised $10.6 million for Blood Cancer United. Meet three leaders who stepped up.

A Phase I/II clinical trial shows that a stem cell transplant that removes CD33 from donor cells using CRISPR can prevent ...

Abstracts highlight strong revumenib activity across the acute leukemia treatment continuum and multiple genetic subtypes –– New real-world ...

Advocates, survivors and community leaders are raising thousands of dollars for research, financial assistance and awareness ...

FDA approved a pill that would change the way scientists treat cancer … for good. The pill was called Gleevec; it was ...